CLINICAL SUPPLY MANAGEMENT ARTICLES
The High Cost Of Zero Waste: Protecting Patients In Clinical Supply
Zero-waste clinical supply models may protect margins, but at what cost to patients and data integrity? Lean trials shift risk in ways sponsors cannot afford to ignore.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Learn how the integral role of Direct-to-Patient Services plays a part in the execution of decentralized trials and how sponsors can maximize these benefits to improve drug development.
-
Discover what happened when the Fountayn Platform, including RTSM, was used to support a client’s two-year, Phase III study seeking a cure for multiple sclerosis.
-
Explore how Interactive Response Technologies (IRTs) built around microservices models can provide faster initial builds, more rapid change management, and improved built-in test automation.
-
Explore the logistical risk management factors to consider when deciding to switch to direct-to-patient shipments in the EU.
-
Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.
-
Challenged by the dispensation of an investigational product (IP) across diverse patient subgroups, see what solution this pharma was able to utilize to ensure optimal distribution and minimize wastage.